Hybrid right-left cardiac resynchronization therapy defibrillator implantation in persistent left superior vena cava

Matteo Anselmino1, Maria Cristina Marocco, Claudia Amellone

  • 1Department of Medicine, Cardiology Unit, University of Turin, Corso Bramante 88, Italy. matt.ans@alice.it

Insights

Persistence of the left superior vena cava (PLSVC) is a rare anomaly affecting transvenous pacing. A hybrid approach for cardiac resynchronization therapy defibrillator implantation in a PLSVC patient proved safe and feasible.

Area of Science:

  • Cardiology
  • Anatomical Variations
  • Electrophysiology

Background:

  • Persistence of the left superior vena cava (PLSVC) is a congenital anomaly occurring in approximately 0.3% of the population.
  • This variation presents unique challenges for cardiovascular procedures, especially transvenous lead implantation.
  • Accurate identification and management strategies are crucial for successful device implantation.

Observation:

  • A patient with PLSVC requiring cardiac resynchronization therapy defibrillator (CRT-D) implantation was encountered.
  • Standard transvenous lead placement approaches were deemed unsuitable due to the anomalous venous anatomy.
  • A hybrid approach combining right-sided access with left-sided lead placement was considered.

Findings:

  • The described hybrid right-left approach for CRT-D implantation in a patient with PLSVC was successfully performed.
  • The procedure was found to be both feasible and safe, demonstrating effective lead placement.
  • This technique offers a viable alternative to surgical implantation in complex cases.

Implications:

  • This hybrid technique provides a valuable alternative for challenging CRT-D implantations in patients with PLSVC.
  • It may reduce the need for cardiac surgical intervention, potentially lowering procedural risks and costs.
  • Further investigation into this approach could refine treatment strategies for patients with complex venous anomalies.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiac Catheterization II: Right Heart Catheterization01:21

Cardiac Catheterization II: Right Heart Catheterization

Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.